---
title: "Squalene Market, Global Outlook and Forecast 2025-2032"
datePublished: Wed Nov 05 2025 05:00:42 GMT+0000 (Coordinated Universal Time)
cuid: cmhlj4xqm000f02jl0o50bcm9
slug: squalene-market-global-outlook-and-forecast-2025-2032

---

# Squalene Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global squalene market size was valued at USD 8.7 million in 2024 and is projected to reach USD 47.9 million by 2032, exhibiting a CAGR of 28.1% during the forecast period. The market is primarily driven by increasing demand from the pharmaceutical and cosmetic industries, with Europe dominating nearly 63% of the global share.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/298013/global-squalene-forecast-market-2025-2032-37">
            https://www.24chemicalresearch.com/download-sample/298013/global-squalene-forecast-market-2025-2032-37</a></b></div><br><p>
</p><p>Squalene is a naturally occurring organic compound, primarily sourced from shark liver oil or plant-based alternatives such as olive oil and sugarcane. It serves as a key ingredient in vaccines, pharmaceuticals, and high-end cosmetics due to its antioxidant and emollient properties. The plant-derived segment currently holds 70% market share, reflecting the industry's shift toward sustainable sourcing practices.</p><p>
</p><p>While vaccines/pharmaceuticals applications account for 51% of total consumption, growth is further propelled by rising health consciousness and premium skincare trends. However, supply chain constraints for shark-derived squalene pose challenges. Key players like Amyris and Clariant are investing in bioengineered alternatives, with YiChun Dahaigui Life Science, Kishimoto, and EFP collectively controlling 78% of the market through advanced production technologies.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Pharmaceutical and Cosmetic Industries Fueling Squalene Demand</strong></p><p>
</p><p>The squalene market is experiencing significant growth due to increasing adoption in pharmaceutical and cosmetic applications. Squalene's superior moisturizing and emollient properties make it a highly sought-after ingredient in premium skincare products, with the global cosmetics market projected to exceed $500 billion by 2027. In pharmaceuticals, squalene's role as an adjuvant in vaccine formulations is driving demand, particularly following advancements in immunization technologies. The compound's ability to enhance immune response has become increasingly valuable in developing novel vaccine formulations, especially for influenza and other viral diseases.</p><p>
</p><p style="text-align:center"><strong>Shift Towards Plant-based Squalene Creating Market Expansion</strong></p><p>
</p><p>Environmental concerns and regulatory restrictions on shark-derived squalene are accelerating the transition to plant-based alternatives, with olive oil and sugarcane emerging as sustainable sources. Plant-derived squalene now accounts for over 70% of global production, as manufacturers respond to consumer preferences for vegan and cruelty-free ingredients. This shift is particularly pronounced in Europe, where regulatory frameworks favor sustainable biomaterials, and where consumers show higher willingness to pay for eco-friendly products. Recent technological innovations in extraction and purification processes have significantly improved the yield and quality of plant-based squalene, making it more cost-competitive with traditional shark-derived variants.</p><p>
</p><p style="text-align:center"><strong>Expanding Vaccine Applications Driving Research Investments</strong></p><p>
</p><p>The critical role of squalene as a vaccine adjuvant continues to stimulate market growth, with recent research highlighting its effectiveness in enhancing immune responses. The global immunology market, valued at over $100 billion, increasingly incorporates squalene-based adjuvants in novel vaccine formulations. The compound's ability to improve antigen presentation and stimulate both humoral and cellular immunity makes it invaluable in vaccine development pipelines. Numerous clinical trials currently underway exploring squalene's potential in next-generation vaccines against emerging pathogens and therapeutic cancer vaccines further underscore its growing importance in modern medicine.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities and Raw Material Scarcity</strong></p><p>
</p><p>The squalene market faces significant constraints due to supply chain complexities and raw material limitations. Traditional shark liver oil extraction methods remain controversial and increasingly regulated, while plant-based alternatives require substantial agricultural resources. Olive oil, a primary plant source, experiences price volatility due to fluctuating crop yields and climate change impacts. These factors contribute to production inconsistencies and pricing pressures, particularly affecting small to medium-sized manufacturers. The time-intensive nature of plant cultivation and extraction processes further exacerbates supply-demand imbalances during peak demand periods.</p><p>
</p><p style="text-align:center"><strong>High Production Costs Limiting Market Penetration</strong></p><p>
</p><p>The sophisticated purification processes required to produce pharmaceutical-grade squalene result in substantially higher production costs compared to industrial-grade variants. Premium prices position squalene as a niche ingredient, restricting its adoption in price-sensitive markets and mass-market cosmetic formulations. Purification technologies, while becoming more efficient, still require significant capital investment, creating barriers to entry for new market participants. These cost factors become particularly challenging in developing regions where price sensitivity limits market expansion despite growing awareness of squalene's benefits.</p><p>
</p><p style="text-align:center"><strong>Regulatory Compliance Burden Increasing Operational Costs</strong></p><p>
</p><p>Stringent regulatory requirements for pharmaceutical and cosmetic applications impose additional challenges on squalene manufacturers. Compliance with Good Manufacturing Practices (GMP) and various regional safety standards necessitates substantial quality control investments. The European Union's evolving cosmetic regulations and the FDA's rigorous approval processes for adjuvants require continuous adaptation from manufacturers. These regulatory complexities particularly impact smaller producers, potentially consolidating market share among established players with greater resources to navigate compliance requirements.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Consumer Perception and Ethical Concerns</strong></p><p>
</p><p>Despite growing market potential, squalene faces persistent challenges related to consumer perception and ethical considerations. Shark-derived products encounter resistance from environmentally conscious consumers and animal rights organizations, even as plant-based alternatives gain traction. Educating consumers about the differences between source types and their respective sustainability profiles requires substantial marketing investments. Furthermore, the cosmetic industry's trend toward "clean labeling" creates additional formulation challenges as manufacturers balance squalene's benefits with consumer preferences for simpler ingredient lists.</p><p>
</p><p style="text-align:center"><strong>Competition from Synthetic Alternatives</strong></p><p>
</p><p>The emergence of bioengineered and synthetic squalene alternatives presents ongoing competitive challenges for traditional producers. Advances in synthetic biology enable the production of squalene through microbial fermentation, offering potentially more scalable and consistent alternatives. While currently representing a small market share, these technologies continue to improve in efficiency and cost-effectiveness. Traditional producers must continuously innovate to maintain their value proposition as these alternatives evolve, particularly in pharmaceutical applications where purity and consistency are paramount.</p><p>
</p><p style="text-align:center"><strong>Technological Barriers in Purification Processes</strong></p><p>
</p><p>Achieving the high purity standards required for pharmaceutical applications remains technically challenging, particularly for plant-derived squalene. Residual plant compounds can complicate purification processes and affect final product quality. Scaling purification technologies while maintaining cost efficiency presents ongoing obstacles, especially for producers targeting the exacting standards of vaccine adjuvants. These technical hurdles limit production volumes and contribute to the premium pricing that constrains broader market adoption.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Expansion in Emerging Markets with Growing Health Awareness</strong></p><p>
</p><p>Developing economies represent substantial growth opportunities as rising disposable incomes and increasing health consciousness drive demand for premium cosmetic and nutraceutical products. Markets in Asia-Pacific and Latin America show particularly strong potential, with consumers increasingly valuing the anti-aging and moisturizing benefits of squalene. The region's expanding middle class and growing pharmaceutical sector create favorable conditions for market expansion. Localized production strategies and targeted marketing could capitalize on these trends, especially as regulatory frameworks in these regions become more conducive to high-quality ingredient adoption.</p><p>
</p><p style="text-align:center"><strong>Innovations in Fermentation-derived Squalene</strong></p><p>
</p><p>Advances in biotechnology present exciting opportunities for alternative squalene production methods. Microbial fermentation techniques utilizing modified yeast strains show promise for sustainable, scalable production. Recent breakthroughs in metabolic engineering have improved yields, potentially revolutionizing supply chain dynamics. These innovations could address current raw material limitations while meeting the growing demand for vegan-certified ingredients. Companies investing in these technologies may gain competitive advantages in both cost structure and sustainability credentials.</p><p>
</p><p style="text-align:center"><strong>Diversification into Novel Therapeutic Applications</strong></p><p>
</p><p>Emerging research suggests promising applications for squalene beyond traditional uses, particularly in drug delivery systems and specialized therapeutics. The compound's biocompatibility and ability to form stable nanoparticles make it attractive for targeted drug delivery applications. Ongoing studies explore its potential in oncology treatments, vaccine stabilization, and even certain neurological applications. As these research pathways mature, they may open entirely new market segments for squalene-based products, particularly in the biopharmaceutical sector where advanced delivery systems command premium pricing.</p><p>
</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Source</strong></p><p>
</p><p><strong>Plant-Based Squalene Surges Ahead as Sustainable Alternative to Shark-Derived Variants</strong></p><p>
</p><p>The market is segmented based on source into:</p><p>
</p><p>Shark Source Squalene</p><p>Plant Source Squalene</p><p>
	</p><p>Subtypes: Olive oil-derived, sugarcane-derived, and others</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Pharmaceutical Applications Drive Demand Due to Squalene's Adjuvant Properties in Vaccines</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Vaccines/Pharmaceuticals</p><p>Health Products/Nutritional products</p><p>Cosmetics and Personal Care</p><p>Industrial Lubricants</p><p>Others</p><p>
<strong>By Purity Grade</strong></p><p>
</p><p><strong>High-Purity Squalene Gains Preference in Biomedical Applications</strong></p><p>
</p><p>The market is segmented based on purity grade into:</p><p>
</p><p>Food Grade</p><p>Cosmetic Grade</p><p>Pharmaceutical Grade</p><p>
<strong>By Distribution Channel</strong></p><p>
</p><p><strong>B2B Transactions Dominate Due to Bulk Industrial Procurement Needs</strong></p><p>
</p><p>The market is segmented based on distribution channel into:</p><p>
</p><p>Direct Sales (B2B)</p><p>Distributors</p><p>Online Retail</p><p>Specialty Stores</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Strategic Expansions &amp; Sustainability Drive Competitive Dynamics</strong></p><p>
</p><p>The global squalene market exhibits a semi-consolidated structure, dominated by a few key players while accommodating mid-sized and emerging competitors. <strong>YiChun Dahaigui Life Science</strong>, <strong>Kishimoto</strong>, and <strong>EFP</strong> collectively hold over <strong>78% market share</strong> as of 2024, demonstrating their stronghold in production and distribution networks. These leaders have cemented their positions through vertical integration, leveraging established supply chains and technological expertise in both plant-based and shark-derived squalene extraction.</p><p>
</p><p>Europe remains the epicenter of squalene demand, accounting for approximately <strong>63% of global consumption</strong>, which has further incentivized regional players like <strong>Clariant</strong> and <strong>Evonik</strong> to expand their production capacities. The dominance of <strong>plant-derived squalene</strong>, occupying <strong>70% of the market</strong>, reflects the industry's gradual shift toward sustainable sourcing, accelerated by tightening environmental regulations and consumer preference for vegan alternatives.</p><p>
</p><p>Meanwhile, <strong>Amyris</strong> has emerged as a disruptive force through its proprietary fermentation technology, enabling cost-effective bio-synthetic squalene production. This innovation aligns with the growing <strong>51% market share</strong> of pharmaceutical applications, particularly vaccine adjuvants â a segment that gained unprecedented traction during the pandemic and continues to drive R&amp;D investments.</p><p>
<strong>List of Key Squalene Companies Profiled</strong></p><p>
</p><p>YiChun Dahaigui Life Science (China)</p><p>Amyris, Inc. (U.S.)</p><p>Kishimoto Special Liver Oil Co. Ltd. (Japan)</p><p>EFP Biotech (Spain)</p><p>Clariant AG (Switzerland)</p><p>VESTAN (Poland)</p><p>Evonik Industries (Germany)</p><p>
</p><p>
<strong>SQUALENE MARKET TRENDS</strong></p><p>
<strong>Expanding Demand in Pharmaceutical Applications Fuels Market Growth</strong></p><p>
</p><p>The global squalene market is experiencing robust growth, primarily driven by its widespread adoption in pharmaceutical and vaccine formulations. As an essential adjuvant in vaccines, squalene enhances immune responses and improves the efficacy of vaccines targeting influenza, COVID-19, and other infectious diseases. With the pharmaceutical sector accounting for over <strong>51% of total market share</strong>, the rising production of biopharmaceuticals and vaccine development programs worldwide is accelerating demand. Europe dominates this segment, holding approximately <strong>63% of the global market</strong>, owing to stringent healthcare regulations and high investments in vaccine research.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Shift Toward Plant-Based Squalene</strong></p><p>
</p><p>The market is witnessing a significant transition from shark-derived squalene to plant-based alternatives, driven by sustainability concerns and regulatory restrictions on marine-sourced ingredients. Plant-derived squalene now holds <strong>70% of the market share</strong>, with olive oil, amaranth seed, and sugarcane emerging as preferred sources. This shift is further reinforced by increasing consumer preference for vegan and cruelty-free products, prompting manufacturers to innovate in bio-synthetic production methods.</p><p>
<strong>Technological Innovations in Extraction and Purification</strong></p><p>
</p><p>Advancements in extraction techniques, such as supercritical CO2 extraction and molecular distillation, are enhancing squalene yield and purity while reducing production costs. Leading players like <strong>YiChun Dahaigui Life Science</strong> and <strong>Amyris</strong> are investing in scalable biotechnological methods to meet the projected <strong>28.1% CAGR</strong> from 2024 to 2032. These innovations are critical to addressing supply chain challenges and ensuring consistent quality, particularly for high-value applications in cosmetics and nutraceuticals, where purity standards are stringent.</p><p>

<strong>Regional Analysis: Squalene Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American squalene market is driven by strong demand from the pharmaceutical and cosmetics industries, particularly in the U.S. and Canada. The region benefits from well-established healthcare infrastructure and growing consumer awareness about the benefits of squalene in vaccines, supplements, and skincare. Regulatory approvals, including its use as an adjuvant in COVID-19 vaccines, have further propelled demand. However, concerns about the sustainability of shark-derived squalene have pushed manufacturers toward plant-based alternatives, particularly olive oil-derived variants. While the market is growing steadily, competition from synthetic alternatives and strict FDA regulations present challenges for suppliers.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe dominates the global squalene market, accounting for <strong>63% of the total share</strong>, with Germany, France, and the U.K. leading demand. The region's strong pharmaceutical sector and emphasis on natural ingredients in cosmetics drive market growth. The EU's stringent regulatory framework ensures high-quality standards, promoting trust in squalene-based products. The shift toward ethical sourcingâfavoring plant-based squalene over shark liver oilâhas been significant due to sustainability regulations under EU REACH. Additionally, increasing R&amp;D investments in biotechnology-derived squalene, like Amyris' fermentation-based process, are reshaping supply chains. Despite market maturity, consumer concerns over synthetic impurities and pricing volatility remain hurdles.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
Asia-Pacific is the fastest-growing region, fueled by expanding healthcare infrastructure and rising disposable incomes in China and India. China alone contributes substantially to production, with companies like YiChun Dahaigui Life Science leading in plant-based squalene manufacturing. The region's high demand for vaccines, coupled with government healthcare initiatives, boosts pharmaceutical applications. Meanwhile, the cosmetics industry increasingly incorporates squalene due to its anti-aging properties. However, cost sensitivity and a preference for shark-derived squalene in some countries create market fragmentation. Long-term growth hinges on sustainability initiatives and regulatory alignment with global standards.</p><p>
</p><p><strong>South America</strong></p><p>
South America shows moderate growth, driven by Brazil and Argentina's evolving pharmaceutical and personal care sectors. The market remains constrained by economic instability and limited local production capabilities, leading to heavy reliance on imports. While plant-based squalene gains traction in premium cosmetic products, price sensitivity and lax environmental regulations slow adoption. Infrastructure challenges and inconsistent supply chains further impede scalability. However, rising health consciousness and gradual investments in biotechnology suggest untapped opportunities for market expansion in the coming years.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The MEA squalene market is nascent yet holds potential due to urbanization and growing healthcare expenditure in the UAE, Saudi Arabia, and South Africa. Demand stems primarily from cosmetics and dietary supplements, with pharmaceutical applications gradually emerging. Limited local production and dependence on imports create supply chain vulnerabilities. While regulatory frameworks are underdeveloped, increasing awareness of sustainable sourcing could drive plant-based squalene adoption. Economic disparities and political instability in some nations, however, continue to restrain market growth, making progress uneven across the region.</p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Squalene, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Squalene manufacturers, suppliers, distributors, and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Squalene Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global Squalene market was valued at <strong>USD 8.7 million in 2024</strong> and is projected to reach <strong>USD 47.9 million by 2032</strong>, growing at a <strong>CAGR of 28.1%</strong> during the forecast period.</p><p>
<strong>Which key companies operate in Global Squalene Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>YiChun Dahaigui Life Science, Kishimoto, EFP, Amyris, Clariant, VESTAN, and Evonik</strong>, among others. The top three players hold a combined market share of over <strong>78%</strong>.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand in pharmaceuticals (especially vaccine adjuvants), increasing adoption in cosmetics, and growing awareness of plant-based squalene alternatives</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Europe</strong> is the largest market with a <strong>63% share</strong>, while <strong>Asia-Pacific</strong> is emerging as the fastest-growing region due to expanding pharmaceutical and cosmetic industries.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>shift from shark-derived to plant-based squalene, increasing R&amp;D for pharmaceutical applications, and sustainable sourcing initiatives</strong>.</p><p>
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/298013/global-squalene-forecast-market-2025-2032-37">
            https://www.24chemicalresearch.com/reports/298013/global-squalene-forecast-market-2025-2032-37</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 Squalene Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global Squalene Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global Squalene Overall Market Size<br />
 2.1 Global Squalene Market Size: 2024 VS 2032<br />
 2.2 Global Squalene Market Size, Prospects & Forecasts: 2020-2032<br />
 2.3 Global Squalene Sales: 2020-2032<br />
3 Company Landscape<br />
 3.1 Top Squalene Players in Global Market<br />
 3.2 Top Global Squalene Companies Ranked by Revenue<br />
 3.3 Global Squalene Revenue by Companies<br />
 3.4 Global Squalene Sales by Companies<br />
 3.5 Global Squalene Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 Squalene Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers Squalene Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 Squalene Players in Global Market<br />
 3.8.1 List of Global Tier 1 Squalene Companies<br />
 3.8.2 List of Global Tier 2 and Tier 3 Squalene Companies<br />
4 Sights by Product<br />
 4.1 Overview<br />
 4.1.1 Segment by Type - Global Squalene Market Size Markets, 2024 & 2032<br />
 4.1.2 Shark Source Squalene<br />
 4.1.3 Plant Source Squalene<br />
 4.2 Segment by Type - Global Squalene Revenue & Forecasts<br />
 4.2.1 Segment by Type - Global Squalene Revenue, 2020-2025<br />
 4.2.2 Segment by Type - Global Squalene Revenue, 2026-2032<br />
 4.2.3 Segment by Type - Global Squale</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/298013/global-squalene-forecast-market-2025-2032-37">
            https://www.24chemicalresearch.com/reports/298013/global-squalene-forecast-market-2025-2032-37</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>